Literature DB >> 22801360

Approaches to decrease the prevalence of depression in later life.

Osvaldo P Almeida1.   

Abstract

PURPOSE OF REVIEW: Depression is a common and disabling disorder that affects people of all ages and 10% of those older than 65 years. Current strategies to decrease the personal and societal burden of depression in older age rely on the management of people with depression or of those at risk, but benefits have been limited and data remain scant. RECENT
FINDINGS: Existing data suggest that decreasing the onset of a depressive disorder in people at risk is a reasonable way of reducing its prevalence in the community. Older adults with subthreshold symptoms of depression and those who have suffered a stroke have been successfully targeted with various interventions. In addition, the use of collaborative care has improved the immediate and long-term outcome of patients with depression. Finally, the findings of epidemiological studies indicate that a more systematic approach to the management of risk factors might improve the outcome of patients and those at risk, but trial data are still lacking.
SUMMARY: Current evidence suggests that it is possible to decrease the prevalence of depression in later life, but a more systematic approach to the assessment and management of older adults is necessary.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801360     DOI: 10.1097/YCO.0b013e328356bd57

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  2 in total

1.  Patients with higher vitamin D levels show stronger improvement of self-reported depressive symptoms in psychogeriatric day-care setting.

Authors:  Stefan Unterecker; Alexandra S Herr; Linda D Zech; Maike Scherf-Clavel; Christine Daniels; Michael Schwab; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2021-07-25       Impact factor: 3.575

2.  Reducing depression during the menopausal transition: study protocol for a randomised controlled trial.

Authors:  Osvaldo P Almeida; Kylie Marsh; Leon Flicker; Martha Hickey; Andrew Ford; Moira Sim
Journal:  Trials       Date:  2014-08-06       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.